Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

Dan Rosmarin, Claire Palles, David Church, Enric Domingo, Angela Jones, Elaine Johnstone, Haitao Wang, Sharon Love, Patrick Julier, Claire Scudder, George Nicholson, Anna Gonzalez-Neira, Miguel Martin, Daniel Sargent, Erin Green, Howard McLeod, Ulrich M Zanger, Matthias Schwab, Michael Braun, Matthew SeymourLindsay Thompson, Benjamin Lacas, Valerie Boige, Nuria Ribelles, Shoaib Afzal, Henrik Enghusen, Søren Astrup Jensen, Marie-Christine Etienne-Grimaldi , Gérard Milano, Mia Wadelius, Bengt Glimelius, Hans Garmo, Milena Gusella , Thierry Lecomte, Pierre Laurent-Puig, Eva Martinez-Balibrea, Rohini Sharma, Jesus Garcia-Foncillas, Zdenek Kleibl, Alain Morel , Jean-Pierre Pignon, Rachel Midgley, David Kerr, Ian Tomlinson

Research output: Contribution to journalArticlepeer-review

153 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences